Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis

“Needs More Research”—Implications of the Proteus Effect for Researchers and Evidence Adopters

(2018) Alex H. Krist   MAYO CLINIC PROCEEDINGS

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

(2018) Alex C. Spyropoulos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of extended thromboprophylaxis for medically ill patients

(2017) Francesco Dentali et al.   THROMBOSIS AND HAEMOSTASIS

Extended thromboprophylaxis with direct oral anticoagulants for medical patients: a systematic review and meta-analysis

(2016) Derrick L. Tao et al.   BLOOD

Conducting and interpreting high-quality systematic reviews and meta-analyses

(2016) Rajat Kalra et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials

(2016) Aaron Y. L. Liew et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

(2016) Alexander T. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility

(2013) Russell D. Hull   ANNALS OF INTERNAL MEDICINE

Prevention of VTE in Nonsurgical Patients

(2012) Susan R. Kahn et al.   CHEST

Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients

(2011) Samuel Z. Goldhaber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quantifying Selective Reporting and the Proteus Phenomenon for Multiple Datasets with Similar Bias

(2011) Thomas Pfeiffer et al.   PLoS One